Slides on Obesity Management Strategies That Can Reap the Benefits of Long-term Weight Loss

Learn how to evaluate and treat patients with obesity with emerging incretin-based therapies to improve long-term weight loss and reduce the risk of obesity-related complications.
person default
Fatima Cody Stanford, MD, MPH, MPA, MBA
Format: Microsoft PowerPoint (.ppt)
File Size: 3.93 MB
Released: June 8, 2021

Acknowledgements

Provided by CE Alliance
PCE Logo

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by
Novo Nordisk Inc.

Related Content

Video from Clinical Care Options (CCO): metabolic adaptations in obesity, value of sustained weight loss, and latest evidence for incretin-based therapies: semaglutide, tirzepatide, and mores

Randy J. Seeley, PhD Jenny Tong, MD, MPH Kristina M. Utzschneider, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: July 26, 2021 Expired: July 25, 2022

Clinical Care Options (CCO) presents Dr. George L. Bakris answering common questions about renoprotection strategies in CKD in T2D

George Bakris, MD Released: July 23, 2021

Practicing Clinicians Exchange presents Fatima Cody Stanford, MD, MPH, MPA, MBA, answering commonly asked questions about the use of GLP-1 receptor agonist pharmacotherapy in obesity management.

person default Fatima Cody Stanford, MD, MPH, MPA, MBA Released: July 22, 2021

Unlocked slides from Elyse Marriner, BSN, RN, CDCES, and Clinical Care Options (CCO): continuous glucose monitoring technologies

Elyse Marriner, BSN, RN, CDCES Released: July 7, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue